A report of 42 patients with type Ⅲ biliary atresia treated by hepatojejunostomy
10.3760/cma.j.issn.1007-8118.2015.08.010
- VernacularTitle:肝门-空肠吻合术治疗Ⅲ型胆道闭锁42例报告
- Author:
Zhongxi ZHANG
;
Li SHEN
;
Pingping ZHANG
;
Chen LI
;
Jinzhong XU
;
Guowei YANG
;
Genling ZHANG
- Publication Type:Journal Article
- Keywords:
Biliary atresia;
Kasai procedure;
Survival rate
- From:
Chinese Journal of Hepatobiliary Surgery
2015;21(8):548-550
- CountryChina
- Language:Chinese
-
Abstract:
Objective To determine the clinical effects of type Ⅲ biliary atresia treated by hepatojejunostomy (Kasai procedure).Methods A retrospective study was performed on patients with type Ⅲ biliary atresia treated in our hospital between January 2009 to December 2013.Results The follow-up data were completed in 42 patients out of 48 patients (87.5％) who underwent Kasai procedure for type Ⅲ biliary atresia.The jaundice disappeared in 31 of 42 patients (73.8％).The rate of patients having cholangitis was 47.6％.There were significant differences in the 2-year survival among the groups of patients with mild cholangitis (75.0％,9/12),serious cholangitis (25.0％,2/8) and without cholangitis (86.4％,19/22) (P ＜ 0.05).Conclusions Hepatojejunostomy (Kasai procedure) is an effective operation to treat type Ⅲ biliary atresia.Our data suggested that the survival rates were related to the degree of bile drainage and cholangitis post surgery.
